FDA Inspection
Staska Pharmaceuticals, Inc.Staska Pharmaceuticals, Inc. – FDA Inspection, Sep 18, 2024
Record Details
This FDA Inspection record concerns Staska Pharmaceuticals, Inc., with an inspection on September 18, 2024, issued by the Kansas City District Office, covering drugs.
View Company Profile
ID · dffc723d-c5d3-4bea-8a2b-9eecceabc624
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1251377
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Staska Pharmaceuticals, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 20, 2026 | Not classified | Kansas City District Office | Drug Quality Assurance |
Other documents for Staska Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.